Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s disease

Author： Easton Amy   Sankaranarayanan Sethu   Tanghe An   Terwel Dick   Lin Alan   Hoque Nina   Bourin Clotilde   Gu Huidong   Ahlijanian Michael   Bristow Linda  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.230, Iss.2, 2013-11, pp. : 279-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease

By Van Dam Debby   Coen Katrien   De Deyn Peter  

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 37-43

Springer Publishing Company

Access to resources Recommend Favorite

The pharmacology of donepezil: a new treatment for Alzheimer’s disease

By Wilkinson D.G.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 121-135

Informa Healthcare

Access to resources Recommend Favorite

Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5076-5084

Bentham Science Publishers

Access to resources Recommend Favorite

A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease

By Wilcock G.  

Drugs & Aging, Vol. 20, Iss. 10, 2003-01 ,pp. : 777-789

Adis International

Access to resources Recommend Favorite

Causes of Syncope in Patients with Alzheimer’s Disease Treated with Donepezil

By Bordier Philippe   Lanusse Stephane   Garrigue Stephane   Reynard Charlotte   Robert Frederic   Gencel Laurent   Lafitte Alexia  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 687-694

Adis International

Access to resources Recommend Favorite